Is detection and treatment of familial hypercholesterolaemia in children indicated?;Is opsporing en behandeling van familiaire hypercholesterolemie geindiceerd bij kinderen?

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 52, 1997, Pages 2548-2550

  Barker, H D ^a   Wiegman, A ^a   Defesche, J C ^b   Kastelein, J J P ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CHILD; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC PREDISPOSITION; HUMAN; METABOLIC DISORDER; NETHERLANDS; NOTE; RECEPTOR GENE; SCREENING;

ADOLESCENT; ADULT; ANTICHOLESTEREMIC AGENTS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DIET, FAT-RESTRICTED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; POINT MUTATION; RECEPTORS, LDL;

EID: 0031588429     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (26)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease, 7th ed. New York: Mc Graw-Hill, 1995:1981-2030.
2. Tuzgol S, Ree MA van de, Defesche JC, Lansberg PJ, Kastelein JJP. Een onderzoek naar het voorkomen van familiaire hypercholesterolemie in vier huisartsenpraktijken. Ned Tijdschr Geneeskd [ter perse].
3. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Human Mutat 1992;1:445-66
4. Day INM The low-density hpopotein receptor (LDLR) gene in familial hypercholesterolemia. WEB-site with mutation catalogue (1997):http://www.ucl.ac.uk/fh.
5. Defesche JC, Pricker KL, Hayden MR, Ende BE van der, Kastelein JJ. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia. Arch Intern Med 1993;153.2349-56.
6. Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 1993;72:171-6.
7. Defesche JC, Lombardi MPR, Kamerling SWA, Havekes LM, Kastelein JJP. Heterogeneity of LDL-recepter mutations in Dutch familial hypercholesterolemia Atherosclerosis 1997;130:S10
8. Defesche JC, Diermen DE van, Lansberg PJ, Lamping RJ, Reymer PWA, Hayden MR, et al. South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population. Hum Genet 1993;92.567-70.
9. Pimstone SN, Defesche JC, Clee SM, Bakker HD, Hayden MR, Kastelein JJP. Differences in the phenotype between children with familial defective apolipoprotein B100 and familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997;17:741-7.
10. Kwiterovich jr PO. Pediatric implications of heterozygous familial hypercholesterolemia. Arteriosclerosis 1989:9(1 Suppl):I111-20
11. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989:9(1 Suppl):I19-32.
12. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants and Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990;264:3018-24.
13. Berenson GS, Wattigney WA, Tracey RE, Newman 3d WP, Srinivasan SR, Webber LS, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study) Am J Cardiol 1992;70:851-8.
14. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993,87(3 Suppl):I156-65.
15. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia Ultrasonographic assessment of intima-media thickness and plaque occurence. Arterioscler Thromb 1993;13:1404-11.
16. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992;340:1430-2.
17. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 1992;340:1111-5.
18. Sorensen KE, Celermajer DS, Georgakopoulos D, Halcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 1994:93 50-5.
19. Stein EA. Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis 1989;(1 Suppl):I145-51.
20. Glueck CJ, Mellies MJ, Dine M, Perry T, Laskarzewski P. Safety and effficacy of long-term diet and diet plus bile acid binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia. Pediatrics 1986;78:338-48
21. Pedersen TR, Tobert JA. Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal. Drug Saf 1996;14:11-24.
22. Ducobu J, Brasseur D, Chaudron JM, Deslypere JP, Harvengt C, Muls E, et al. Simvastatin use in children [letter]. Lancet 1992. 339:1488.
23. Knipscheer HC, Boelen CCA, Kastelein JJP, Diermen DE van, Groenemeijer BE, Ende A van den, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996,39:867-71.
24. Vandenbroucke JP. Screening op familiaire hypercholesterolemie. Ned Tijdschr Geneeskd 1996;140:944-8.
25. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 1994;344:1383-9.
26. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.